You Don’t Have To Spend $25,000 On This – William Rosellini

By William Rosellini – A necessary part of raising funds, drafting your Private Placement Memorandum, or PPM, is a process that is costly and painstaking. Whether using fund managers or attorneys, it typically runs into the thousands, and that’s money that could be better used in any startup. Saving you time, money, and from mistakes unclear to a first-time founder or CEO is what Funding Coach is about, and here’s our answer to how and why you don’t have to spend $25,000 on this.

Starting at the beginning, what is a PPM? A PPM is an offering document used by companies to get investors on board, which details what the investment opportunity is, the potential return on investment and risks, and any other legal disclosures that cover the company. Essentially, it is a document outlining everything a prospective investor needs to know before pouring any money into your venture.

About :

William Rosellini is the President of CytoImmune Therapeutics, Inc, a clinical stage biotechnology company. Previously, William Rosellini was the CEO of Perimeter Medical, Inc. (TSX:V “PINK”) where he oversaw 2 510K clearances, an RTO and $30M in capital raised. Prior to that William Rosellini was the CEO Nexeon Medsystems, Inc., (“OTC:QB, NXNN”)a medicaldevice manufacturing company that went public in 2017. Before that William Rosellini founded, raised $16M across A/B rounds and led Lexington Technology Group, LLC, a database company commercializing an electronic health record database solution to an exit (“DSS” NYSE). Before that William Rosellini founded Sarif Biomedical LLC, a stereotactic cancer microsurgery with IP spun-out of Medtronic and led company to an exit with Marathon Patent Group, Inc. (“MARA” NSDQ). William Rosellini subsequently served on the Marathon board of directors and chaired the Audit committee. William Rosellini completed 2 acquisitions to form Telemend Medical, Inc. a clinical engineering services company and led that company to an exit in 2016. William Rosellini was also CEO at Microtransponder, an implantable neurostimulation developer with solutions for stroke rehabilitation. William Rosellini is a former minor league pitcher with the Diamondbacks of the Arizona League, holds a JD, MBA, MS of Accounting, MS of Computational Biology, MS of Neuroscience and MS of Regulatory Science.

Sign-up to receive free tools to support raising investment capital

Leave a Comment

Your email address will not be published. Required fields are marked *